2025
Novel Approaches for Treating Anxiety and Trauma-Related Disorders
Kaye A, Jefferson S, Krystal J. Novel Approaches for Treating Anxiety and Trauma-Related Disorders. 2025, 583-598. DOI: 10.1093/med/9780197640654.003.0043.Peer-Reviewed Original ResearchNeural plasticityNeural circuitsAnxiety spectrum disordersTreatment-resistant populationModulation of neural circuitsExtinction learningFear extinctionBurden of anxietyThreat responsesTreat anxietyPsychedelic drugsSpectrum disorderImprove anxietyAnxietyPathological perceptionCurrent treatmentReceptor targetsPsychotherapyAntidepressantsAnxiolyticsExtinctionDisordersKetaminePlasticityTreatment
2024
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer
Petridis P, Grinband J, Agin-Liebes G, Kinslow C, Zeifman R, Bogenschutz M, Griffiths R, Ross S. Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer. Nature Mental Health 2024, 2: 1408-1414. DOI: 10.1038/s44220-024-00331-0.Peer-Reviewed Original ResearchPsilocybin-assisted psychotherapyInterpersonal sensitivityObsession-compulsionPsychiatric symptomsPsychiatric symptom dimensionsMental health treatmentPlacebo-controlled crossover trialSymptom dimensionsAnxiety disordersTreating moodHealth treatmentImprove anxietyCancer-related distressAnxietyDepressionPsychotherapyPhobiaPsychosisParanoiaSomatizationHostilityCrossover trialSymptomsMultiple dimensionsClinical improvementMindfulness-based therapy for insomnia in Black women: a pilot randomized controlled trial
Nam S, Jeon S, Ordway M, Mazure C, Sinha R, Yau L, Iennaco J. Mindfulness-based therapy for insomnia in Black women: a pilot randomized controlled trial. Journal Of Behavioral Medicine 2024, 47: 1094-1106. PMID: 39306634, DOI: 10.1007/s10865-024-00521-2.Peer-Reviewed Original ResearchPatient Health Questionnaire-9Spielberger State-Trait Anxiety InventoryInsomnia Severity IndexHealth educationMindfulness-based therapyBlack womenDepressive symptomsEfficacy of mindfulness-based therapyAttention control groupSleep health disparitiesPost-intervention changesState-Trait Anxiety InventoryPittsburgh Sleep Quality IndexInsomnia severity scoresSleep Quality IndexInsomnia Severity Index scoreBehavioral sleep strategiesRandomized Controlled TrialsClinically significant improvementPhysical activityHealth disparitiesHealthy eatingSleep hygiene practicesImprove anxietyWeekly sessions
2020
Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial
Tajdini M, Aminorroaya A, Tavolinejad H, Tofighi S, Jalali A, Sadeghian S, Akhondzadeh S, Vasheghani-Farahani A, Yadangi S, Shahmansouri N, Bozorgi A. Atomoxetine in patients with recurrent vasovagal syncope for preventing vasovagal attacks and improvement of depression and anxiety: a randomized double-blind placebo-controlled clinical trial. European Heart Journal 2020, 41: ehaa946.0713. DOI: 10.1093/ehjci/ehaa946.0713.Peer-Reviewed Original ResearchPre-syncopal episodesImprove anxietyRecurrent vasovagal syncopeVasovagal syncopeEffects of atomoxetineSyncopal episodesImprovement of depressionPrimary endpointSignificant between-subjects effectAbstract Background StudiesHospital Anxiety and Depression ScaleAnxiety and Depression ScaleDouble-blind placebo-controlled randomized clinical trialPlacebo-controlled randomized clinical trialBetween-subject effectsPreventing recurrence of syncopeMonths of follow-upAtomoxetineCompared to placeboDepression scoresRecurrence of syncopeAnxietyDepressionDepression ScaleMann-Whitney U test
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply